|
Sign In to gain access to subscriptions and/or personal tools.
|
Microchimerism and human autoimmune diseases
J L Nelson
Program in Human Immunogenetics, Fred Hutchinson Cancer Research Center, and Rheumatology, University of Washington, Seattle, Washington, USA; Immunogenetics D2-100, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, Seattle, WA 98109-1024, USA; lnelson{at}fhcrc.org
Cells traffic in both directions between the fetus and the mother during pregnancy. Recent studies indicate that a low level of fetal cells commonly persists in the maternal circulation for years after pregnancy completion.The harboringof DNA or cells from another individual at low levels is called microchimerism. Chronic graft-vs-host disease is a condition of human chimerism that shares similaritiesto some autoimmune diseasesand for which the specific HLA genes of donor and host are known to be of central importance. Considered together with the female predilection to autoimmunity, these observations led to the hypothesis that microchimerism and HLA genes of host and non-host cells are involved in autoimmune disease. The hypothesis also extends to men and females who have not been pregnant because there are other sources of microchimerism. Maternal cells are now know to persist in her progeny and microchimerism can also derive from a twin or from a blood transfusion. Studies of systemic sclerosis, primary biliary cirrhosis, Sjögrens syndrome, polymorpyhic eruption of pregnancy, myositis and thyroid disease have both lent support and raised doubts about the role of microchimerism in autoimmune disease.
Key Words: autoimmune disease microchimerism
Lupus, Vol. 11, No. 10,
651-654 (2002)
DOI: 10.1191/0961203302lu271oa

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. M. Gill, T.-H. Lee, G. H. Utter, W. F. Reed, L. Wen, D. Chafets, and M. P. Busch
The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients
Blood,
April 1, 2008;
111(7):
3880 - 3883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Stark, L. Dierkx, V. L. Clifton, and I. M. R. Wright
Alterations in the Maternal Peripheral Microvascular Response in Pregnancies Complicated by Preeclampsia and the Impact of Fetal Sex
Reproductive Sciences,
December 1, 2006;
13(8):
573 - 578.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Raghavan and P. E. Marik
Anemia, Allogenic Blood Transfusion, and Immunomodulation in the Critically Ill
Chest,
January 1, 2005;
127(1):
295 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Reed, K. McNallan, P. Wettstein, R. Vehe, and C. Ober
Does HLA-Dependent Chimerism Underlie the Pathogenesis of Juvenile Dermatomyositis?
J. Immunol.,
April 15, 2004;
172(8):
5041 - 5046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Murashima, T Fukazawa, M Hirashima, Y Takasaki, M Oonishi, S Niijima, Y Yamashiro, A Yamataka, T Miyano, and H Hashimoto
Long term prognosis of children born to lupus patients
Ann Rheum Dis,
January 1, 2004;
63(1):
50 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamada, A. Koizumi, H. Iso, Y. Wada, Y. Watanabe, C. Date, A. Yamamoto, S. Kikuchi, Y. Inaba, H. Toyoshima, et al.
Risk Factors for Fatal Subarachnoid Hemorrhage: The Japan Collaborative Cohort Study
Stroke,
December 1, 2003;
34(12):
2781 - 2787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Storb, G. Lucarelli, P. A. McSweeney, and R. W. Childs
Hematopoietic Cell Transplantation for Benign Hematological Disorders and Solid Tumors
Hematology,
January 1, 2003;
2003(1):
372 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|